Hongli Group Inc Dossier
Financial Snapshot
Revenue, profitability, returns, debt, and capital allocation
Revenue $19.6M+39.0% YoYTTM through 31 Dec 2025
Net Income $1.9MTTM through 31 Dec 2025
Free Cash Flow $660.8KTTM through 31 Dec 2025
Margins
| Current | |
|---|---|
| Gross Margin | 32.5% |
| EBITDA Margin | 16.5% |
| Operating Margin | 12.7% |
| Net Margin | 9.9% |
Returns
3.4%ROE
2.7%ROA
2.8%ROIC
Balance Sheet Health
Debt / Equity0.20x
Current Ratio1.12x
Net Debt$9.6M
Cash & Equivalents$1.8M
Quality Metrics
Altman Z-Score6.92
Piotroski F-Score5 / 9
FCF Margin3.4%
Multi-Year Trend
RevenueFY2025: $19.6M
Diluted EPS$0.03TTMFY2025: $0.03
Dividend
No dividend
Capital Allocation
R&D Spend$994.5K
Capex Intensity1.1%
Segment Performance
| Segment | Revenue | YoY | Outlook |
|---|---|---|---|
| PRC Domestic Sales | $16.6M | +36.1% | |
| International Sales | $3M | +58.2% |
Filing Detail Members
This section is available to registered members. Create a free account or sign in to unlock the full breakdown.